SCHEMBL7213490

SCHEMBL7213490

NC(=O)[C@@H]1CCN(Cc2csc3ccnc(Cl)c23)C1=O

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
F10 P00742 8/20 0.40
F2 P00734 6/20 0.40
PLG P00747 5/20 0.40
PLAT P00750 5/20 0.40
PROC P04070 5/20 0.40
MET P08581 1/20 0.32
ALDH1A1 P00352 1/20 0.32
EIF2AK1 Q9BQI3 1/20 0.32
EIF2AK3 Q9NZJ5 1/20 0.32
KDR P35968 2/20 0.32
PRSS1 P07477 3/20 0.31
ADORA1 P30542 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7456508 1.00 F10 (0.40) F10F2PLGPLATPROC
SCHEMBL7456514 0.85 F10 (0.38) F10F2PLGPLATPROC
SCHEMBL7213494 0.85 F10 (0.38) F10F2PLGPLATPROC
SCHEMBL7214400 0.83 F10 (0.40) F10F2PLGPLATPROC
SCHEMBL7448311 0.83 F10 (0.40) F10F2PLGPLATPROC
Trifluoroacetic Acid SCHEMBL7219132 0.83 KDR (0.35) F10F2PLGPLATPROC
Trifluoroacetic Acid SCHEMBL7219407 0.83 KDR (0.35) F10F2PLGPLATPROC
Trifluoroacetic Acid SCHEMBL7446696 0.83 KDR (0.35) F10F2PLGPLATPROC
Trifluoroacetic Acid SCHEMBL7219220 0.82 F2 (0.34) F10F2PLGPLATPROC
Trifluoroacetic Acid SCHEMBL7213546 0.82 F2 (0.34) F10F2PLGPLATPROC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6602864-B1 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-08-05 US disclosed
EP-0944386-B1 SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS AVENTIS PHARMA INC (US) 2002-09-18 EP disclosed
US-6281227-B1 INHIBITORS OF THE ACTIVITY OF FACTOR XA. AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-08-28 US disclosed